Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Irinotecan plus lobaplatin vs irinotecan in relapsed SCLC
NCT03613753Phase 2Unknown
- Start
- Jun 2018
- Primary completion
- Jun 2020
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of lobaplatin in small cell lung cancer (SCLC). Status: unknown.
02
Drugs
lobaplatin
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on NCT03613753.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03613753.